Executive Summary
This digest covers $390,576,263 in total obligations across 6 Federal IT & Cybersecurity contracts, all civilian agency awards with 0 defense-related, spanning HHS/CMS, HUD, State, DOE, and VA. Dominant theme is steady civilian IT infrastructure and application support spending, led by HHS/CMS at ~$133M combined for VENTERA LLC ($83.7M) and Flexion Inc ($49.1M). Highest-conviction bullish signal is VENTERA LLC's $83.7M CMS QualityNet order with $58.8M already outlayed, signaling strong execution in healthcare IT. Key risk is high pricing risk on firm-fixed price structures across multiple awards like Microtechnologies LLC's $76.5M HUD contract; watch outlay progress and option exercises amid medium-term performance periods to 2027.
Tracking the trend? Catch up on the prior Federal IT & Cybersecurity Contracts digest from May 06, 2026.
Investment Signals (4)
- VENTERA LLC Secures $83.7M CMS IT Infrastructure Order (HIGH)▲
VENTERA LLC awarded $83,737,440 firm-fixed price delivery order by CMS for QualityNet services, with $58,789,105 outlayed since April 2023 on a 4+ year term to 2027-04-30.
- General Dynamics IT Wins $71.9M State Department Consular Support Task (MEDIUM)▲
General Dynamics Information Technology Inc. received $71,911,936 firm-fixed price order from Department of State for consular IT support, with potential ceiling to $208M through 2033.
- Accenture Federal Services Lands $55.4M DOE IT Development BPA Call (MEDIUM)▲
Accenture Federal Services LLC secured $55,356,320 time-and-materials BPA call from DOE, with $49,114,481 outlayed since March 2024 on 3.5-year term to 2027-09-06.
- Microtechnologies LLC $76.5M HUD GNMA Support Nears Completion (MEDIUM)▲
$45,916,611 outlayed on $76,499,975 firm-fixed price order to Microtechnologies LLC for HUD GNMA licensing, with performance ending 2025-12-20.
Risk Flags (3)
- Execution [HIGH RISK]▼
General Dynamics Information Technology Inc. $71.9M State order has $0 outlayed since June 2023 award, signaling potential delays in funding or startup.
- Budget [HIGH RISK]▼
High pricing risk on firm-fixed price contracts like VENTERA LLC $83.7M CMS and Microtechnologies LLC $76.5M HUD amid non-linear outlays.
- Competition [MEDIUM RISK]▼
Post-2025 expiration of Microtechnologies LLC $76.5M HUD order and partial execution on Solventum $53.9M VA contract risk re-competes.
Opportunities (3)
- ◆
VENTERA LLC and Flexion Inc. CMS awards totaling $132.9M highlight healthcare IT expansion via small business set-asides.
- ◆
General Dynamics IT $71.9M State order with $208M ceiling offers multi-year upside through 2033 if options exercised.
- ◆
Small business set-asides enabled VENTERA LLC $83.7M CMS and Flexion Inc $49.1M CMS wins despite private status.
Sector Themes (2)
- ◆
HHS/CMS awarded $132.9M combined to VENTERA LLC ($83.7M QualityNet) and Flexion Inc ($49.1M claims adjudication), both with strong outlays ($58.8M and $31.9M).
- ◆
DOE ($55.4M Accenture), State ($71.9M GD IT), and VA ($53.9M Solventum) focus on business apps and facilities management with partial/high outlays.
Watch List (4)
- 👁
{"entity"=>"VENTERA LLC", "reason"=>"$83.7M CMS obligation with $58.8M outlayed; track toward $101.7M ceiling.", "trigger"=>"Option exercises and 2027-04-30 end"}
- 👁
{"entity"=>"General Dynamics Corp", "reason"=>"$71.9M State order at $0 outlayed with $208M potential.", "trigger"=>"Outlay initiation post-2023-06-13 award"}
- 👁
{"entity"=>"Accenture", "reason"=>"$55.4M DOE with $49.1M outlayed toward $63.8M ceiling.", "trigger"=>"Incremental funding and 2027-09-06 end"}
- 👁
{"entity"=>"Microtechnologies LLC", "reason"=>"$76.5M HUD nearing end with $30.6M remaining.", "trigger"=>"2025-12-20 expiration and follow-on awards"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 6 filings
More from: Federal IT & Cybersecurity Contracts
🇺🇸 More from United States
View all →May 06, 2026
US Pre-Market SEC Filings Roundup — May 06, 2026
US Pre-Market SEC Filings Roundup
May 06, 2026
New Drug Approvals (Original) — May 06, 2026
New Drug Approvals (Original)
May 06, 2026
Orphan Drug Approvals — May 06, 2026
Orphan Drug Approvals
May 06, 2026
Biotech Small-Cap Approvals — May 06, 2026
Biotech Small-Cap Approvals